Cargando…
Metformin inhibits estrogen‐dependent endometrial cancer cell growth by activating the AMPK–FOXO1 signal pathway
Metformin is an oral biguanide commonly used for treating type II diabetes and has recently been reported to possess antiproliferative properties that can be exploited for the prevention and treatment of a variety of cancers. The mechanisms underlying this effect have not been fully elucidated. Our...
Autores principales: | Zou, Jingfang, Hong, Liangli, Luo, Chaohuan, Li, Zhi, Zhu, Yuzhang, Huang, Tianliang, Zhang, Yongneng, Yuan, Huier, Hu, Yaqiu, Wen, Tengfei, Zhuang, Wanling, Cai, Bozhi, Zhang, Xin, Huang, Jiexiong, Cheng, Jidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198961/ https://www.ncbi.nlm.nih.gov/pubmed/27636742 http://dx.doi.org/10.1111/cas.13083 |
Ejemplares similares
-
AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma
por: Cheng, Jidong, et al.
Publicado: (2014) -
High Uric Acid Induces Insulin Resistance in Cardiomyocytes In Vitro and In Vivo
por: Zhi, Li, et al.
Publicado: (2016) -
Metformin Targets Foxo1 to Control Glucose Homeostasis
por: Guo, Xiaoqin, et al.
Publicado: (2021) -
Metabolic regulation by the intestinal metformin-AMPK axis
por: Zhang, Song-Yang, et al.
Publicado: (2022) -
Metformin Protects From Rotenone–Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis
por: El-Ghaiesh, Sabah H., et al.
Publicado: (2020)